Selective inhibition of TNF-α-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib

We have reported that the selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, gefitinib (‘Iressa’, ZD1839), suppressed intrahepatic metastasis of hepatocellular carcinoma CBO140C12 cells. In this study, we focused on the tumour necrosis factor-α (TNF-α) signalling pathways....

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Y, Sakurai, H, Matsuo, M, Choo, M K, Koizumi, K, Saiki, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362047/
https://www.ncbi.nlm.nih.gov/pubmed/15841081
http://dx.doi.org/10.1038/sj.bjc.6602548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362047/
https://www.ncbi.nlm.nih.gov/pubmed/15841081
http://dx.doi.org/10.1038/sj.bjc.6602548

Ejemplares similares